EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Micro-physiological system of human lung: The current status and application to drug discovery

Naoyuki Sone, Shimpei Gotoh

Drug Metabolism and Pharmacokinetics · 2025

DOI: 10.1016/j.dmpk.2024.101050 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Metabolism and Pharmacokinetics, 2025. Verfasst von Naoyuki Sone und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan. Hauptthemen laut MEDLINE: Drug Discovery, Lung. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 103 Literaturangaben. Gefördert von: Mochida Memorial Foundation for Medical and Pharmaceutical Research, JSPS, Kyoto University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various attempts have been made to elucidate the mechanisms of human lung development, its physiological functions, and diseases, in the hope of new drug discovery. Recent technological advancements in experimental animals, cell culture, gene editing, and analytical methods have provided new insights and therapeutic strategies. However, the results obtained from animal experiments are often inconsistent with those obtained from human data because of reproducibility issues caused by structural and physiological differences between mice and humans. In addition, it is not possible to accurately reproduce the internal environment of the human lung structure using conventional two-dimensional (2D) or three-dimensional (3D) cell culture methods. As a result, the micro-physiological system (MPS) technology, such as "lung-on-a-chip" that can culture human cells in a state close to human body environment have been developed, and its applications to disease models, toxicological studies, and drug discovery are accelerated worldwide. Here, we focus on the mimetics of the lung, including "lung-on-a-chip" technology, and review their recent progress, achievements and challenges. Finally, we discuss the role of these chips in drug discovery for refractory lung diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryLungHumansAnimalsLab-On-A-Chip DevicesLung Diseases

Stichwörter der Autor:innen

Disease modelDrug discoveryLung-on-a-chipMicro-physiological system

Autor:innen und Institutionen

  • Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.
  • Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan. Electronic address: gotoh.shimpei.5m@cira.kyoto-u.ac.jp.

Förderung

  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • JSPS
  • Kyoto University
  • Universita degli Studi del Piemonte Orientale Amedeo Avogadro
  • Japan Agency for Medical Research and Development
  • Canadian Internet Registration Authority
  • Japan Society for the Promotion of Science

Zitieren

APA

Sone, N., & Gotoh, S. (2025). Micro-physiological system of human lung: The current status and application to drug discovery. Drug Metabolism and Pharmacokinetics. https://doi.org/10.1016/j.dmpk.2024.101050

Vancouver

Sone N, Gotoh S. Micro-physiological system of human lung: The current status and application to drug discovery. Drug Metabolism and Pharmacokinetics. 2025. doi:10.1016/j.dmpk.2024.101050

BibTeX
@article{Sone2025,
  author = {Sone, Naoyuki and Gotoh, Shimpei},
  title = {Micro-physiological system of human lung: The current status and application to drug discovery},
  journal = {Drug Metabolism and Pharmacokinetics},
  year = {2025},
  doi = {10.1016/j.dmpk.2024.101050}
}
Kostenlos starten →